Aequus Pharmaceuticals
(OTC) AQSZF
Aequus Pharmaceuticals Financials at a Glance
Market Cap
$238,700
Revenue (TTM)
$918.47K
Net Income (TTM)
$656.34K
EPS (TTM)
$-0.00
P/E Ratio
-0.53
Dividend
$0.00
Beta (Volatility)
-7.08 (Low)
Dividend
$0.00
Beta (Volatility)
-7.08 (Low)
Price
$0.00
Volume
10,000
Open
$0.00
Price
$0.00
Volume
10,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
-7.08 (Low)
Price
$0.00
Volume
10,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
AQSZF News
AQSZF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aequus Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
15
CEO
Douglas Glen Janzen
Website
www.aequuspharma.caHeadquarters
Vancouver, BC V6C 1S4, CA
AQSZF Financials
Key Financial Metrics (TTM)
Gross Margin
53%
Operating Margin
-62%
Net Income Margin
-71%
Return on Equity
0%
Return on Capital
8%
Return on Assets
-3%
Earnings Yield
-1.89%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$238.70K
Shares Outstanding
132.63M
Volume
10.00K
Short Interest
0.00%
Avg. Volume
12.49K
Financials (TTM)
Gross Profit
$332.30K
Operating Income
$2.13M
EBITDA
$1.79M
Operating Cash Flow
$1.66M
Capital Expenditure
$0.00
Free Cash Flow
$1.66M
Cash & ST Invst.
$50.24K
Total Debt
$6.61M
Aequus Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$251.75K
+69.7%
Gross Profit
$132.07K
+75.1%
Gross Margin
52.46%
N/A
Market Cap
$238.70K
N/A
Market Cap/Employee
$19.89K
N/A
Employees
12
N/A
Net Income
$370.48K
+160.3%
EBITDA
$308.31K
+160.0%
Quarterly Fundamentals
Net Cash
$4.32M
+33.7%
Accounts Receivable
$165.75K
+154.1%
Inventory
$3.54K
-96.4%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$4.33M
-28.4%
Return on Assets
-3.35%
N/A
Return on Invested Capital
8.33%
N/A
Free Cash Flow
$0.00
+100.0%
Operating Cash Flow
$0.00
+100.0%